Tag: TECHNOLOGY

sovaSage Introduces AI-Powered Clinical Indicator Intelligence™
Artificial Intelligence

sovaSage Introduces AI-Powered Clinical Indicator Intelligence to Advance PAP Patient Management

sovaSage™ announced the new release of Clinical Indicator Intelligence™, an enhanced feature within sovaGuide™ featuring Jeanie™. Using machine learning, the new capability continuously analyzes multiple PAP therapy variables to help providers identify patients who may require additional clinical evaluation before therapy challenges lead to reduced benefit or treatment abandonment. The […]

New SANSA Platform Enhancements & Cardiovascular Risk Data to be Presented at SLEEP 2026
Industry News Technology

Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker

Huxley Medical, a commercial-stage medical technology company expanding access to sleep apnea testing across health systems, cardiology, and primary care, today introduced two additions to its SANSA® platform: SANSA GO™, a point-of-care enrollment model that enables clinics to dispense SANSA at patient visits, and hypoxic burden, an additional measure of […]

Exit 156 Capital and NightWare Announce Strategic Investment Partnership
Industry News Partnerships

NightWare Announce Strategic Investment Partnership

NightWare, Inc. and Exit 156 Capital announced a strategic investment by Exit 156 in NightWare’s ongoing Series C financing. NightWare is the maker of the only FDA-cleared prescription digital therapeutic indicated for nightmare disorder in adults with post-traumatic stress disorder (PTSD). The partnership unites a Minneapolis-based growth-stage digital health company […]

AAN Issues Guidance on the Use of Wearable Devices
Product News

AAN Issues Guidance on Wearable Devices

Wearable devices and digital apps that are available to consumers are emerging as potential tools in neurological care. These include smart watches and fitness trackers to monitor heart rate, physical activity, sleep and other health factors. To provide neurologists with guidance on the use, limitations and evidence on non-U.S. Food […]

ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
Sleep Disorders

ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine

ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]